Reply to letter to editor “public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany”
Open Access
- 5 January 2026
- journal article
- Published by Taylor & Francis in Expert Review of Vaccines
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in GermanyExpert Review of Vaccines, 2025
- Costs and Complications of Respiratory Syncytial Virus and Acute Respiratory Infections in the Adult Population: Analysis of a German Claims DatabasePharmacoEconomics - Open, 2025
- Detection of community‐acquired respiratory viruses in allogeneic stem‐cell transplant recipients and controls—A prospective cohort studyTransplant Infectious Disease, 2020
- Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomesTransplant Infectious Disease, 2020
- Microbiologic Diagnostic Workup of Acute Respiratory Failure with Pulmonary Infiltrates after Allogeneic Hematopoietic Stem Cell Transplantation: Findings in the Era of Molecular- and Biomarker-Based AssaysTransplantation and Cellular Therapy, 2018
- Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitBone Marrow Transplantation, 2013
- Molecular Characterization of a Respiratory Syncytial Virus Outbreak in a Hematology Unit in Heidelberg, GermanyJournal of Clinical Microbiology, 2013
- Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from Pneumocystis pneumoniaJournal of Infection, 2009
- Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control studyThorax, 2003